Trem
Trem Ltd. is a London-based health technology company developing an AI-powered tremor tracking platform and proprietary medical-grade wearable that delivers validated digital biomarkers to pharmaceutical companies and CROs running essential tremor clinical trials.
- Company typePrivate
- Founded2024
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Trem does
Trem Ltd. is a London-based health technology company building an AI-powered tremor tracking platform and a proprietary medical-grade wearable for the essential tremor clinical research market. The platform combines four software modules — Digital Endpoints, Patient Engagement Platform, Trial Workflow Automation, and Data Insights & AI Models — that together capture tremor motion via the wearable, convert it into validated digital biomarkers, automate routine clinical trial workflows, and apply large language models and predictive analytics to support regulatory submissions. Trem's go-to-market targets pharmaceutical companies and Contract Research Organizations running essential tremor trials, positioning itself as a B2B infrastructure layer for patient-centric, decentralized studies rather than a consumer health tool.
Trem firmographics
Firmographics- Name
- Trem
- Legal name
- Trem Ltd.
- Website
- https://trem.app
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Trem Ltd. is a London-based health technology company developing an AI-powered tremor tracking platform and proprietary medical-grade wearable that delivers validated digital biomarkers to pharmaceutical companies and CROs running essential tremor clinical trials.
- Ownership category
- akta.pro rank
Trem industry classification
Industry- Product category
- Clinical Trial Technology
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK)
- akta.pro secondary industries
- Electronic Data Capture (EDC) Platforms (HLACAOAA), Clinical Trial Management Systems (CTMS) (HLACAOAD), Neurology RPM (epilepsy, Parkinson’s, MS monitoring) (HLALAFAJ)
Keywords
Where Trem is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Trem business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Platform and Software Services: B2B SaaS model providing digital endpoints, patient engagement tools, and trial workflow automation to pharma companies and CROs. Revenue likely derived from platform subscriptions and service fees for clinical trial technology solutions.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Trem product offering
Product offeringCore offering
Trem develops an AI-powered tremor analysis platform paired with a medical-grade wearable that continuously captures tremor data from patients and transforms it into validated digital biomarkers for use in clinical trials. The offering is built for pharmaceutical companies and Contract Research Organizations running neurology-focused studies.
Product overview
Trem offers a unified digital health platform comprising four core software modules—Digital Endpoints, Patient Engagement Platform, Trial Workflow Automation, and Data Insights & AI Models—designed to accelerate tremor care innovation. These modules work together to capture tremor data via a medical-grade wearable, transform it into validated digital biomarkers, enable AI-powered patient communication and decentralized trial participation, automate clinical trial workflows, and apply large language models and advanced analytics for regulatory-grade insights. The platform is specifically built for pharma companies and clinical research organizations conducting essential tremor trials.
Differentiator
Problem solved
Functional benefit
Products and services
- Digital Endpoints Validated digital biomarkers derived from continuous tremor capture, delivered to pharma sponsors and CROs as clinical trial endpoints for neurology studies.
- Patient Engagement Platform Patient-facing tooling that supports onboarding, adherence, and remote participation of trial participants in tremor-focused clinical trials.
- Trial Workflow Automation Automation of trial workflows around wearable data ingestion, quality checks, and endpoint generation for site and sponsor study teams.
- Data Insights & AI Models AI- and LLM-based analytics that convert raw tremor sensor data into tremor quantification, longitudinal insights, and endpoints for clinical and biomarker use.
- Medical-Grade Wearable Proprietary medical-grade wearable device worn by trial participants to continuously capture tremor kinematics at home and in clinic.
Quantifiable outcome
- Essential Tremor is 10x more prevalent than Parkinson's
Companies that use Trem
Customer profileSegments2 records
Ideal customer profiles2 records
Trem technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature5 records
Trem partnerships and signals
Strategic signalScale indicators3 records
Recent moves4 records
Expansion highlights5 records
Trem competitors and assessment
Company assessmentDirect peers
- Empatica: Empatica develops medical-grade wearables and digital biomarkers for neurological conditions including epilepsy and Parkinson's. It is the closest direct competitor to Trem: a clinical-grade wearable feeding validated digital endpoints into pharma and CRO trial pipelines.
- VivoSense: VivoSense develops regulatory-grade digital endpoints and wearable sensor analytics for clinical trials. It competes with Trem in the validated-endpoint-for-pharma layer, particularly in neurology and movement disorders.
- Cumulus Neuroscience: Cumulus Neuroscience builds a digital biomarker platform for neurology clinical trials, including movement-disorder assessments. It is a direct peer in the neurology-focused digital-endpoint category Trem is targeting.
- ActiGraph: ActiGraph manufactures clinical-grade wearable actigraphy sensors used in pharmaceutical trials and academic research. Its wearable-and-analytics approach to objective movement measurement parallels Trem's hardware-plus-software model.
- Biofourmis: Biofourmis combines a wearable biosensor with AI analytics to support remote patient monitoring and decentralized clinical trials. It overlaps with Trem across the wearable + RPM + trial workflow stack and targets the same pharma and CRO buyers.
- Koneksa Health: Koneksa provides digital biomarker solutions and remote patient monitoring for clinical trials across multiple therapeutic areas. Its pharma-facing evidence-generation platform directly overlaps with Trem's digital endpoints and patient engagement stack.
Emerging players
- Huma Therapeutics: Huma provides a digital health platform for decentralized and hybrid clinical trials, combining a patient app, remote monitoring, and biomarker capture. It overlaps with Trem's Patient Engagement and workflow modules as a comparable DCT infrastructure player.
- Castor: Castor offers an eClinical platform (EDC, ePRO, DCT) used by pharma and CROs. It overlaps with Trem at the digital-endpoint, PRO-capture, and decentralized trial engagement layers.
Broad incumbents
- Medidata (Dassault Systèmes): Medidata is the leading EDC and CTMS platform for clinical trials, owned by Dassault Systèmes. Trem's Trial Workflow Automation and Digital Endpoints compete at the edge of Medidata's data-capture and trial-operations footprint.
- Verily Life Sciences: Verily (Alphabet) develops wearable sensors and digital health platforms for clinical research and care. Its broader portfolio and resources position it as a potential acquirer or competitor for AI-driven neurology digital biomarker platforms.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Trem social profiles
Digital presenceTrem financial estimates
Financial estimateRevenue estimate
Valuation estimate
Trem leadership team
Management profileNumber of profiles
Profiles1 record
Trem funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Trem M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Trem
What does Trem do?
Trem develops an AI-powered tremor analysis platform paired with a medical-grade wearable that continuously captures tremor data from patients and transforms it into validated digital biomarkers for use in clinical trials. The offering is built for pharmaceutical companies and Contract Research Organizations running neurology-focused studies.
Is Trem a public or private company?
Trem is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Trem founded?
Trem was founded in 2024. It employs 1 to 10 people.
Where is Trem based?
Trem is headquartered in London, United Kingdom, in the Europe region.
How does Trem make money?
One revenue line is on record: platform and Software Services.
Who are Trem's main competitors?
Direct peers on record are Empatica, VivoSense, Cumulus Neuroscience, ActiGraph, Biofourmis and Koneksa Health. Emerging players are Huma Therapeutics and Castor. Broad incumbents are Medidata (Dassault Systèmes) and Verily Life Sciences.
Does Trem have an API?
No public API is recorded for Trem.
What industry is Trem in?
Trem's product category is Clinical Trial Technology. Its primary akta.pro industry code is HLALABAK, Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms, with a secondary code of HLACAOAA, Electronic Data Capture (EDC) Platforms. Its NAICS code is 334510 and its SIC code is 3845.